ArticleAnnals of medicine and surgery (2012)2025
Bardet-Biedl syndrome in a Syrian adolescent: a rare case report.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bardet-Biedl Syndrome (BBS) is a rare genetic disorder that affects multiple organs and presents with a variety of characteristics. It was found that a dysfunction in the cilia causes it, in addition to mutations in the genes involved in the composition of these cilia. We present a unique case of BBS in a 13-year-old male from Syria, characterized by a significant family history of scleroderma and a distinct clinical presentation. Case presentation: The patient presented with intellectual disabilities, post-axial polydactyly, and a history of delayed developmental milestones. The patient's BMI was within the normal range. Laboratory investigations revealed increased TSH and positive calcium oxalate, without evidence of central obesity or blindness. The diagnosis of BBS was made with a moderate level of confidence. The patient was undergoing treatment with thyroxine, showing improvement in thyroid function and communication skills. Clinical discussion: This case highlights the manifestations of BBS and the importance of recognizing atypical presentations. Diagnostic criteria traditionally emphasize a combination of primary and secondary features. We discuss the challenges of diagnosing BBS without genetic testing and the implications for treatment in resource-limited settings. Additionally, we explore therapeutics in managing the patient's condition. Conclusion: This case represents a unique presentation of BBS, expanding the understanding of its clinical variability in different populations. The findings underscore the necessity for individualized diagnostic approaches and comprehensive management strategies in patients with limited access to genetic testing. By documenting this case, we contribute to the growing body of literature on BBS, particularly in the Syrian context, highlighting the need for increased awareness and research into this challenging disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.